EMAIL THIS PAGE TO A FRIEND

International immunology

B-CLL cells acquire APC- and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21.


PMID 24497611

Abstract

CpG oligodeoxynucleotides (CpG) and IL-21 are two promising agents for the treatment of B-cell chronic lymphocytic leukemia (B-CLL). Recently, we reported that the combination of CpG and IL-21 (CpG/IL-21) can induce granzyme B (GrB)-dependent apoptosis in B-CLL cells. Here, we demonstrate that treatment of B-CLL cells with CpG and IL-21 results in the development of antigen-presenting cell (APC)-like cells with cytotoxic features. These properties eventually give rise to B-CLL cell apoptosis, independently of their cytogenetic phenotype, whereas normal B-cell survival is not negatively affected by CpG/IL-21. APC- and CTL-typical molecules found to be up-regulated in CpG/IL-21-stimulated B-CLL cells include GrB, perforin, T-bet, monokine-induced by IFN-γ and IFN-γ-inducible protein 10 (IP-10), as well as molecules important for cell adhesion, antigen cross-presentation and costimulation. Also induced are molecules involved in GrB induction, trafficking and processing, whereas the GrB inhibitor Serpin B9 [formerly proteinase inhibitor-9 (PI-9)] is down-modulated by CpG/IL-21. In conclusion, CpG/IL-21-stimulated B-CLL cells acquire features that are reminiscent of killer dendritic cells, and which result in enhanced immunogenicity, cytotoxicity and apoptosis. Our results provide novel insights into the aberrant immune state of B-CLL cells and may establish a basis for the development of an innovative cellular vaccination approach in B-CLL.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

H56800
2-Hydroxypyridine, 97%
C5H5NO
SAB1300809 Anti-BCR (N-term) antibody produced in rabbit, saturated ammonium sulfate (SAS) precipitated, buffered aqueous solution
SAB1401029
Anti-BCR antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
HPA038337
Anti-BCR antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4502657
Anti-BCR antibody produced in rabbit, affinity isolated antibody
SAB2105133
Anti-CD5, (N-terminal) antibody produced in rabbit, affinity isolated antibody
Y0001256
Levetiracetam impurity C, European Pharmacopoeia (EP) Reference Standard
C5H5NO
SAB1402126
Monoclonal Anti-BCR antibody produced in mouse, clone 2E5, purified immunoglobulin, buffered aqueous solution
SAB4100025
Monoclonal Anti-CD5 antibody produced in mouse, culture supernatant
SAB4700066 Monoclonal Anti-CD5 antibody produced in mouse, clone CRIS1, purified immunoglobulin, buffered aqueous solution
SAB4700071 Monoclonal Anti-CD5 antibody produced in mouse, clone MEM-32, purified immunoglobulin, buffered aqueous solution
SAB4700730 Monoclonal Anti-CD5 antibody produced in mouse, clone L17F12, purified immunoglobulin, buffered aqueous solution
PLA0233
Rabbit anti-BCR Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.
PLA0234
Rabbit anti-BCR Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.